Area of research
Genetics · Physiology
Research interest
Research interests include Glioma Diagnosis and Treatment, Alzheimer's disease research and treatments, Immunotherapy and Immune Responses, and Neuroinflammation and Neurodegeneration Mechanisms.
Early Locus Coeruleus noradrenergic axon loss drives olfactory dysfunction in Alzheimer’s disease
Long-term diazepam treatment enhances microglial spine engulfment and impairs cognitive performance via the mitochondrial 18 kDa translocator protein (TSPO)
Fourier Transform Infrared Microscopy Enables Guidance of Automated Mass Spectrometry Imaging to Predefined Tissue Morphologies
Vaccine Strategies in Gliomas
Author Correction: Fourier Transform Infrared Microscopy Enables Guidance of Automated Mass Spectrometry Imaging to Predefined Tissue Morphologies
Immuntherapien bei Gliomen
K27M-mutant histone-3 as a novel target for glioma immunotherapy
The promises of immunotherapy in gliomas
Synergy of vaccination and agonist OX40 treatment—toward a mechanism-driven combination of glioma immunotherapy
P06.06 A mutation-specific vaccine for Histone-3 K27M-mutated gliomas
Immuntherapien bei Gliomen
Correlated magnetic resonance imaging and ultramicroscopy (MR-UM) is a tool kit to assess the dynamics of glioma angiogenesis
OS2.4 Expression and relevance of tumoral and stromal MHC class II in gliomas
P02.03 Multiple sclerosis and gliomas - a coincidence?
Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors
Tryptophan‐2,3‐dioxygenase is regulated by prostaglandin E2 in malignant glioma via a positive signaling loop involving prostaglandin E receptor‐4
Author response: Correlated magnetic resonance imaging and ultramicroscopy (MR-UM) is a tool kit to assess the dynamics of glioma angiogenesis
Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR
Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway
Microenvironmental Clues for Glioma Immunotherapy
O6.09 * PROSTAGLANDIN E RECEPTOR-4 ACTIVATION REGULATES TRYPTOPHAN METABOLISM IN HUMAN MALIGNANT GLIOMAS
Immature mesenchymal stem cell-like pericytes as mediators of immunosuppression in human malignant glioma